Iron oxide nanoparticles for therapeutic applications - Sorbonne Université
Journal Articles Drug Discovery Today Year : 2020

Iron oxide nanoparticles for therapeutic applications

Abstract

In nanomedicine, iron oxide nanoparticles are at an advanced stage, being commercialized for cancer treatment and iron-deficiency anemia treatment. Their therapeutic efficacy comes from their ability to target a tissue, activate a drug, locally produce a temperature increase following (or not) the application of an external source of energy, modify genes or activate various biological materials, or replace diseased cells by stem cells. Owing to these various mechanisms of action, they can potentially be used for treating a whole range of different diseases, making them more appealing than conventional drugs that target a more limited number of indications.
Fichier principal
Vignette du fichier
S1359644619303800.pdf (1.08 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-02441707 , version 1 (21-07-2022)

Licence

Identifiers

Cite

Edouard Alphandéry. Iron oxide nanoparticles for therapeutic applications. Drug Discovery Today, 2020, 25 (1), pp.141-149. ⟨10.1016/j.drudis.2019.09.020⟩. ⟨hal-02441707⟩
103 View
164 Download

Altmetric

Share

More